Apolipoprotein B for the refinement of cardiovascular risk assessment

1

Apolipoprotein B (ApoB) provides a broader assessment of cardiovascular risk compared to LDL cholesterol (LDL-C) and non-HDL cholesterol (non-HDL-C).
2

Discordantly high ApoB levels correlate with increased cardiovascular event rates, while discordantly low levels correlate with decreased rates, independent of absolute lipid levels.
3

The study utilized a percentile difference approach to define ApoB/LDL-C discordance, offering a more detailed analysis than median-based methods.
4

VLDL particle count significantly mediates cardiovascular risk in individuals with discordantly high ApoB, highlighting the role of triglyceride-rich lipoproteins.
5

Current guidelines recommend ApoB measurement in specific populations, but its clinical utility may vary based on the presence of other metabolic risk factors.

1